Portier H - Search Results

1

Candidemia in critically ill patients: difference of outcome between medical and surgical patients.

Charles PE, Doise JM, Quenot JP, Aube H, Dalle F, Chavanet P, Milesi N, Aho LS, Portier H, Blettery B. Charles PE, et al. Among authors: portier h. Intensive Care Med. 2003 Dec;29(12):2162-2169. doi: 10.1007/s00134-003-2002-x. Epub 2003 Sep 10. Intensive Care Med. 2003. PMID: 13680110

2

Influence of positive end-expiratory pressure (PEEP) on histopathological and bacteriological aspects of pneumonia during low tidal volume mechanical ventilation.

Charles PE, Martin L, Etienne M, Croisier D, Piroth L, Lequeu C, Pugin J, Portier H, Chavanet P. Charles PE, et al. Among authors: portier h. Intensive Care Med. 2004 Dec;30(12):2263-70. doi: 10.1007/s00134-004-2442-y. Epub 2004 Nov 4. Intensive Care Med. 2004. PMID: 15536527 Free PMC article.

3

The impact of mechanical ventilation on the moxifloxacin treatment of experimental pneumonia caused by Streptococcus pneumoniae.

Charles PE, Etienne M, Croisier D, Piroth L, Lequeu C, Pugin J, Portier H, Chavanet P. Charles PE, et al. Among authors: portier h. Crit Care Med. 2005 May;33(5):1029-35. doi: 10.1097/01.ccm.0000163404.35338.72. Crit Care Med. 2005. PMID: 15891332

4

New model of ventilator-associated pneumonia in immunocompetent rabbits.

Charles PE, Piroth L, Desbiolles N, Lequeu C, Martin L, Portier H, Chavanet P. Charles PE, et al. Among authors: portier h. Crit Care Med. 2002 Oct;30(10):2278-83. doi: 10.1097/00003246-200210000-00016. Crit Care Med. 2002. PMID: 12394956

5

[Treatment of acute pharyngitis].

Chavanet P, Portier H. Chavanet P, et al. Among authors: portier h. Rev Prat. 1992 Feb 1;42(3):303-7. Rev Prat. 1992. PMID: 1579819 Review. French.

6

[New strategies for angina case management in France].

Portier H, Grappin M, Chavanet P. Portier H, et al. Bull Acad Natl Med. 2003;187(6):1107-16. Bull Acad Natl Med. 2003. PMID: 14978871 Review. French.

7

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, Grappin M, Buisson M, Waldner A, Portier H, Chavanet P. Piroth L, et al. Among authors: portier h. AIDS. 1998 Mar 5;12(4):381-8. doi: 10.1097/00002030-199804000-00006. AIDS. 1998. PMID: 9520167

8

[New macrolides].

Portier H, Buisson M, Chavanet P. Portier H, et al. Rev Prat. 1994 Jun 15;44(12):1629-34. Rev Prat. 1994. PMID: 7939238 Review. French.

9

HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.

Piroth L, Desbiolles N, Mateo-Ponce V, Martin L, Lequeu C, Charles PE, Portier H, Chavanet P. Piroth L, et al. Among authors: portier h. J Antimicrob Chemother. 2001 Jan;47(1):33-42. doi: 10.1093/jac/47.1.33. J Antimicrob Chemother. 2001. PMID: 11152429

10

Therapeutic trials in HIV infection: which benefits for which patients?

Piroth L, Callerot JY, Grappin M, Duong M, Buisson M, Portier H, Chavanet P. Piroth L, et al. Among authors: portier h. HIV Clin Trials. 2001 Jan-Feb;2(1):22-30. doi: 10.1310/2V79-XX17-M0XT-EEWL. HIV Clin Trials. 2001. PMID: 11590511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters